Position | Company | Period |
---|
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
12,805
-40.2%
0.678,618 USD |
12,805 -40.2% | 0.67 | 8,618 USD | |
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
5,309
-40.5%
0.673,573 USD |
5,309 -40.5% | 0.67 | 3,573 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
5,220
-39.9%
0.854,458 USD |
5,220 -39.9% | 0.85 | 4,458 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
4,009
-39.6%
0.843,354 USD |
4,009 -39.6% | 0.84 | 3,354 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
4,440
-37.9%
1.868,250 USD |
4,440 -37.9% | 1.86 | 8,250 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,100
-38.9%
1.691,863 USD |
1,100 -38.9% | 1.69 | 1,863 USD | |
2022-08-01 | 2022-08-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,983
-38.2%
1.775,290 USD |
2,983 -38.2% | 1.77 | 5,290 USD | |
2022-07-05 | 2022-07-05 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,973
-38.9%
1.683,311 USD |
1,973 -38.9% | 1.68 | 3,311 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
4,368
-37.3%
3.1913,942 USD |
4,368 -37.3% | 3.19 | 13,942 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,076
-38.1%
3.543,813 USD |
1,076 -38.1% | 3.54 | 3,813 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
3,770
-37.3%
3.5613,409 USD |
3,770 -37.3% | 3.56 | 13,409 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,070
-37.9%
4.064,349 USD |
1,070 -37.9% | 4.06 | 4,349 USD | |
2021-01-19 | 2021-01-19 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
4,358
-37.2%
5.6724,708 USD |
4,358 -37.2% | 5.67 | 24,708 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,058
-37.5%
6.156,509 USD |
1,058 -37.5% | 6.15 | 6,509 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,065
-37.7%
5.335,674 USD |
1,065 -37.7% | 5.33 | 5,674 USD | |
2020-08-04 | 2020-08-03 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
4,823
-37.4%
9.2544,613 USD |
4,823 -37.4% | 9.25 | 44,613 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,144
-40.5%
5.135,874 USD |
1,144 -40.5% | 5.13 | 5,874 USD | |
2020-01-07 | 2020-01-06 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
1,148
-40.6%
1.201,378 USD |
1,148 -40.6% | 1.20 | 1,378 USD |